Home › Stocks › ABOS › All Fund Holders
ABOS — ACUMEN PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 33 · Reported value held: $32.32M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 2.49M | $6.65M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 2.31M | $6.15M | 0.00% | Hold |
| Janus Henderson Group history | Q4 2021 | 627.26K | $4.24M | 0.00% | Reduce |
| Vanguard Group history | Q4 2025 | 1.65M | $3.49M | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 1.14M | $3.05M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 675.02K | $1.80M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 622.88K | $1.66M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 360.74K | $963.19K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 274.78K | $733.66K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 183.93K | $491.08K | 0.00% | Reduce |
| Wellington Management Group history | Q1 2024 | 112.26K | $454.64K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 136.76K | $365.16K | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 124.38K | $332.09K | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 115.10K | $307.31K | 0.00% | New |
| Millennium Management history | Q2 2026 | 60.60K | $161.80K | 0.00% | Reduce |
| Point72 Asset Management history | Q1 2026 | 67.38K | $159.00K | 0.00% | Add |
| Moore Capital Management history | Q4 2022 | 27.58K | $148.92K | 0.00% | Reduce |
| Citadel Advisors history | Q2 2026 | 51.05K | $136.30K | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2024 | 55.01K | $133.12K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 49.69K | $132.66K | 0.00% | Add |
| Manulife Financial history | Q3 2024 | 52.33K | $129.79K | 0.00% | Reduce |
| Marshall Wace history | Q2 2026 | 48.11K | $128.47K | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 46.13K | $123.17K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 25.77K | $68.79K | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 24.59K | $65.65K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 21.89K | $58.44K | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 20.16K | $55.85K | 0.00% | New |
| AQR Capital Management history | Q2 2025 | 46.29K | $53.70K | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 11.87K | $31.70K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q2 2026 | 7.53K | $20.11K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 4.61K | $12.31K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 3.08K | $8.22K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 39.33K | $106 | 0.00% | New |